SUMMARYThe polyoxotungstate HPA-23 was found to exert a differential effect on the induction of Epstein-Barr virus early antigen in Raji cells induced with 5-iodo-2'-deoxyuridine (IUdR). Thus, treatment of Raji cells concomitantly with IUdR and HPA-23 inhibited early antigen expression, and the extent of inhibition was proportional to the duration of treatment with HPA-23. In contrast, pretreatment of Raji cells with HPA-23 prior to induction with IUdR stimulated early antigen expression in exponentially multiplying but not in stationary-phase ceils. HPA-23 alone had no effect on early antigen expression in Raji cells. Activation of the latent Epstein-Barr virus genome by IUdR is dependent upon incorporation of the thymidine analogue into cellular DNA during the S-phase of the cell cycle. Synthesis of EpsteinBarr virus DNA also takes place during S-phase, suggesting a possible participation in this process of cellular DNA polymerase ct which is thought to be responsible for cellular DNA replication and the activity of which increases several-fold during Sphase. Treatment of Raji cells with HPA-23 caused a marked decrease in DNA polymerase ct activity, which could result in an inhibition of IUdR incorporation leading to the observed reduction of early antigen expression in ceils treated concomitantly with IUdR and HPA-23.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.